Microgynon

Phase 1Small molecule

Boehringer Ingelheim

Microgynon is one of 84 small molecule programs targeting Interstitial Lung Disease. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Interstitial Lung DiseaseActive, not recruiting

Non-Small Cell Lung CancerActive, not recruiting

Interstitial Lung DiseasePhase 1

Active, not recruiting

Non-Small Cell Lung CancerPhase 1

Active, not recruiting

Competition

Competitive Landscape

1639 competitors in Non-Small Cell Lung Cancer

#DrugCompanyPhaseTrials

Yervoy

Bristol-Myers Squibb

Preclinical

31 2

Gemzar

GGynecologic Oncology Group

Preclinical

72 3

PORTRAZZA

Eli Lilly

Preclinical

8 4

Vizimpro

Pfizer

Preclinical

4 5

Gilotrif

Boehringer Ingelheim

Preclinical

12 6

Ofev

Boehringer Ingelheim

Preclinical

7 7

Immunotherapy

Bristol-Myers Squibb

Preclinical

12 8

Remeron

OOrganon and Co

Preclinical

1 9

PD-1 Inhibitor

Johnson & Johnson

Preclinical

2 10

Tyrosine Kinase Inhibitor

Pfizer

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Oral2 trials

A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers

Completed· Roche logo

Roche·Phase 1·NCT01615354·18 enrolled

Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel

Terminated· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT01941615·18 enrolled

Interstitial Lung Disease1 trial

A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT03675581·17 enrolled

Menopause1 trial

A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

Completed· Novo Nordisk logo

Novo Nordisk·Phase 1·NCT05153564·27 enrolled

ARDS1 trial

Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol

Completed· Bayer logo

Bayer·Phase 1·NCT02170038·16 enrolled

Semaglutide1 trial

A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

Completed· Novo Nordisk logo

Novo Nordisk·Phase 1·NCT02845219·25 enrolled

11 more indications

Baricitinib1 trial

A Study of Baricitinib and Birth Control Pills in Healthy Females

Completed· Eli Lilly logo

Eli Lilly·Phase 1·NCT01896726·20 enrolled

Interaction1 trial

Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)

Completed· Bayer logo

Bayer·Phase 1·NCT03210246·71 enrolled

Female1 trial

A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age

Completed· GSK logo

GSK·Phase 1·NCT06354257·20 enrolled

Hemostasis1 trial

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Completed· Bayer logo

Bayer·Phase 4·NCT00651846·43 enrolled

Women1 trial

A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT05613777·19 enrolled

Non-Small Cell Lung Cancer1 trial

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

Terminated· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02751385·2 enrolled

Postmenopausal Women1 trial

Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women

Completed· Bayer logo

Bayer·Phase 1·NCT02159326·31 enrolled

Recurrence1 trial

Comparing the Use of Dienogest and Combined Oral Contraceptive Pills (Microgynon) to Reduce the Risk of Recurrence of Endometriotic Cyst After Conservative Surgery

Unknown status·TThe University of Hong Kong·Phase 4·NCT02385448·144 enrolled

Overweight1 trial

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT05896384·32 enrolled

Premenopausal1 trial

Effect of Multiple BI 1356 Doses of on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Healthy Female Premenopausal Subjects

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 1·NCT02175394·18 enrolled

Unspecified2 trials

Effects of Cladribine Tablets on the PK of Microgynon®

Completed· Merck & Co. logo

Merck & Co.·Phase 1·NCT03745144·28 enrolled

Effects of SH T00658ID on Libido

Completed· Bayer logo

Bayer·Phase 3·NCT00764881·217 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for Microgynon. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Microgynon compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Microgynon. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Boehringer Ingelheim company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: Boehringer Ingelheim

Microgynon

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Oral2 trials

Interstitial Lung Disease1 trial

Menopause1 trial

ARDS1 trial

Semaglutide1 trial

Baricitinib1 trial

Interaction1 trial

Female1 trial

Hemostasis1 trial

Women1 trial

Non-Small Cell Lung Cancer1 trial

Postmenopausal Women1 trial

Recurrence1 trial

Overweight1 trial

Premenopausal1 trial

Unspecified2 trials

References

Drug Info

Quick Facts

Related News